These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Gupta U; Jain NK Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Sosnik A; Carcaboso AM; Glisoni RJ; Moretton MA; Chiappetta DA Adv Drug Deliv Rev; 2010 Mar; 62(4-5):547-59. PubMed ID: 19914315 [TBL] [Abstract][Full Text] [Related]
6. A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro. Urbán P; Estelrich J; Cortés A; Fernàndez-Busquets X J Control Release; 2011 Apr; 151(2):202-11. PubMed ID: 21223986 [TBL] [Abstract][Full Text] [Related]
8. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Huh AJ; Kwon YJ J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369 [TBL] [Abstract][Full Text] [Related]
9. Nano-facilitated drug delivery strategies in the treatment of plasmodium infection. Puttappa N; Kumar RS; Kuppusamy G; Radhakrishnan A Acta Trop; 2019 Jul; 195():103-114. PubMed ID: 31039335 [TBL] [Abstract][Full Text] [Related]
11. [Malaria during pregnancy: consequences and interventional perspectives]. Cot M; Deloron P Med Trop (Mars); 2003; 63(4-5):369-80. PubMed ID: 14763291 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in targeting malaria with nanotechnology-based drug carriers. Rashidzadeh H; Tabatabaei Rezaei SJ; Adyani SM; Abazari M; Rahamooz Haghighi S; Abdollahi H; Ramazani A Pharm Dev Technol; 2021 Oct; 26(8):807-823. PubMed ID: 34190000 [TBL] [Abstract][Full Text] [Related]
13. Active targeting of brain tumors using nanocarriers. Béduneau A; Saulnier P; Benoit JP Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726 [TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856 [TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of malaria in pregnancy: opportunities and challenges. Rogerson SJ; Menendez C Expert Rev Anti Infect Ther; 2006 Aug; 4(4):687-702. PubMed ID: 17009946 [TBL] [Abstract][Full Text] [Related]
16. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Singh KK; Vingkar SK Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216 [TBL] [Abstract][Full Text] [Related]
17. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. Muller RH; Keck CM J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654 [TBL] [Abstract][Full Text] [Related]
18. [Liposome-mediated delivery system in prophylaxis and therapy of malaria]. Zhang HB Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):245-8. PubMed ID: 12568038 [No Abstract] [Full Text] [Related]
19. Lipid nanocapsules: a new platform for nanomedicine. Huynh NT; Passirani C; Saulnier P; Benoit JP Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468 [TBL] [Abstract][Full Text] [Related]
20. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Na-Bangchang K; Karbwang J Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]